SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-023799
Filing Date
2017-11-14
Accepted
2017-11-14 16:46:12
Documents
3
Period of Report
2017-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bold-8k_20171114.htm 8-K 32663
2 EX-99.1 bold-ex991_8.htm EX-99.1 151674
3 GRAPHIC g201711140546035627066.jpg GRAPHIC 5248
  Complete submission text file 0001564590-17-023799.txt   192876
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 171202363
SIC: 2836 Biological Products, (No Diagnostic Substances)